Longidaze<sup>®</sup>

Longidaze®

International non-proprietary name: bovhyarulonidase azoximer

An advanced sustained release enzyme for combined therapy of connective tissue hyperplasia diseases (adhesion, scarring, or fibrous processes).

Used in gynecology, urology, dermatovenerology, pulmonology, orthopedics, surgery, esthetic medicine, and otolaryngology.

Dosage forms: suppositories, and lyophilizate for solution for infusion.

Go to the website


© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.